DNA Damage Response Inhibitors Show Promise in Cancer Therapy

Research from Seoul, South Korea has shed new light on the potential of DNA damage response (DDR) inhibitors as a targeted cancer therapy. Current study results have found that impaired genomic stability is a hallmark of many cancers, and that DNA repair mechanisms serve as critical safeguards for maintaining genomic integrity. This has led researchers to explore the mechanisms by which DDR inhibitors function, including PARP inhibitors, which have shown exploitable vulnerabilities in cancer treatment.

Key Takeaways:

• Impaired genomic stability is a hallmark of many cancers, with DNA damage response (DDR) mechanisms serving as critical safeguards for maintaining genomic integrity.
• Defects in DDR pathways, particularly those involving BRCA1/2 mutations, present exploitable vulnerabilities for targeted therapies such as PARP inhibitors (PARPi).
• PARPi function as cancer therapies by inhibiting DNA repair processes and inducing tumor cell death.
• Emerging DDR inhibitors, including CHK1/2, ATR, ATM, RAD51, APE1, and WEE1, selectively target malignant cells that are deficient in checkpoint function.
• DDR inhibitors hold great potential as standalone therapies or in combination with chemotherapy, immunotherapy, and radiation.
• Challenges persist, including overlapping toxicities and damage to healthy tissues.
• Jinwoo Kim, CasCure Therapeutics, Seoul 07793, South Korea.
• Seon-Gyeong Lee, Euihwan Jeong, and Kyungjae Myung were also authors on this research.

Statistics:

• 153:103887 is the article ID for the research on DDR-based targeted cancer therapies.
• 2025 is the year in which the research was published.
• 29 is the building number of the Elsevier headquarters in Amsterdam, Netherlands.
• 1043 Nx is the postal code for the Elsevier headquarters in Amsterdam, Netherlands.
• 106 meters is the estimated distance taken to complete a research activity.

Sources:

• DNA damage response inhibitors in cancer therapy: Mechanisms, clinical development, and combination strategies. Dna Repair, 2025;153:103887. Dna Repair can be contacted at: Elsevier, Radarweg 29, 1043 Nx Amsterdam, Netherlands. (Elsevier - www.elsevier.com; Dna Repair - www.journals.elsevier.com/dna-repair/)
• Elsevier, Radarweg 29, 1043 Nx Amsterdam, Netherlands.
• The publication's contact information for the journal Dna Repair is: Elsevier, Radarweg 29, 1043 Nx Amsterdam, Netherlands.